Seroquel in Bipolar Depression Versus SSRI

Completed · Phase 3

Conditions studied: Bipolar Disorder, Bipolar Depression, Depression

In brief

The purpose of this study is to determine whether quetiapine is effective and safe in the acute treatment of bipolar depression and whether the effect is maintained when treatment is continued.

Key facts

Study ID
NCT00119652
Run by
AstraZeneca
People needed
676
Starts
2005-05-01
Expected to finish
2007-05-01
Last updated by the study team
2013-01-04

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.